For the Inventor, By the Inventor

Enter assignee name

San Diego, CA, United States of America

Illumina Corporation

USPTO Granted Patents = 1,107

CIPO Patents = 52

EPO Patents = 368

Trademarks = 80

Forward Citations = 18,522

Loading Chart...

Loading Chart...

842 inventors (with patents filed for the assignee):

Kevin L Gunderson (90 out of 116 patents)

Tarun Kumar Khurana (77 out of 83 patents)

M Shane Bowen (69 out of 69 patents)

4. John A Moon (65 out of 86 patents)

5. Mark S Chee (49 out of 182 patents)

6. Robert C Kain (49 out of 56 patents)

7. Wenyi Feng (46 out of 47 patents)

8. Frank J Steemers (45 out of 47 patents)

9. Stanley S Hong (44 out of 47 patents)

10. Erik Allegoren (40 out of 41 patents)

11. John R Stuelpnagel (38 out of 49 patents)

12. James Michael Osmus (37 out of 38 patents)

13. Min-Jui Richard Shen (36 out of 41 patents)

14. Molly Min He (34 out of 59 patents)

15. Boyan Boyanov (34 out of 83 patents)

Core Competencies:

Polynucleotide Sequencing

Nucleic Acid Synthesis Techniques

Fluorescence Excitation

Cell Isolation

Genomic Data Analysis

Artificial Intelligence Base Caller

Flow Cells

CRISPR-Cas Systems

Deep Convolutional Neural Networks

Library Preparation

Fluidic Devices

Structured Illumination Microscopy

1,107 patents: Sort by Forward Citations

1. 12510555 - Systems and related pump manifold assemblies (2025-12-30),

2. 12508587 - Multilayer fluidic devices and methods for their fabrication (2025-12-30),

3. D1107250 - Flow cell cartridge (2025-12-23),

4. 12505511 - AI-driven enhancement of motion blurred sequencing images (2025-12-23),

5. 12502669 - Systems, methods, and apparatuses to image a sample for biological or chemical analysis (2025-12-23),

6. 12499974 - Quality detection of variant calling using a machine learning classifier (2025-12-16),

7. 12498347 - Systems and devices for high-throughput sequencing with semiconductor-based detection (2025-12-16),

8. 12497657 - Nucleic acid sequencing system (2025-12-16),

9. 12497656 - Independently removable nucleic acid sequencing system and method (2025-12-16),

10. 12493024 - Scalable circuit for molecular detection (2025-12-09),

11. 12492750 - Flow cell assemblies and related systems (2025-12-09),

12. 12491488 - Microarrays, hybridization seals, and related methods (2025-12-09),

13. D1104049 - Display screen with a graphical user interface (2025-12-02),

14. D1103182 - Display screen or portion thereof with graphical user interface (2025-11-25),

15. 12484331 - Enabling sensor top side wirebonding (2025-11-25),

Illumina Corporation is an American company that develops, manufactures and markets integrated systems for the analysis of genetic variation and biological function. It provides sequencing and array-based solutions for genetic and genomic analysis, allowing researchers to explore DNA at an unprecedented scale. Illumina's products and services are widely used in various fields such as life sciences research, clinical research, oncology, reproductive health, and agriculture. With a focus on improving human health through genomics, Illumina continually innovates and collaborates with the scientific community to enhance understanding of complex biological systems.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

1,107 Patents

#3 in San Diego, CA

#109 in California

#453 in US

#903 in the World

San Diego, CA, United States of America

Illumina Corporation

Forward Citations = 18,522

842 inventors:

Kevin L Gunderson (90 out of 116 patents)

Tarun Kumar Khurana (77 out of 83 patents)

M Shane Bowen (69 out of 69 patents)

4. John A Moon (65 out of 86 patents)

5. Mark S Chee (49 out of 182 patents)

Please report any incorrect information to support@idiyas.com

Loading…